PT141 research peptide vial — Axiom
≥99% Purity
HPLC Tested
Worldwide
Research & Therapeutic

PT141

Melanocortin receptor agonist

CODE · P41
From €30/ vial
Research summary

PT141 (Bremelanotide) is studied as a melanocortin-4 receptor agonist for sexual function research.

Key research highlights
  • MC4R agonist
  • Sexual function research
  • Single strength

Composition & Pricing

Variant1 amp10+ amps
10mg*10vials
P41
30.0018.00

10+ ampules: −40% bulk discount applied automatically.

For research purposes only. Not for human consumption, diagnostic, or therapeutic use. Must be handled by qualified laboratory professionals.